+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genmab AS - logo

Genmab is a leading biotechnology company that focuses on developing innovative antibody products. Arzerra is the company’s first marketed antibody and is approved to treat chronic lymphocytic leukemia (CLL) patients in all major markets. Another product, Darzalex, has been approved in the United States for the treatment of patients with multiple myeloma. Genmab was founded in Copenhagen, Denmark in 1999 and employs around 200 people.

Global Lymphoma Antibodies Market & Clinical Trials Insight 2028 - Product Thumbnail Image

Global Lymphoma Antibodies Market & Clinical Trials Insight 2028

  • Report
  • May 2022
  • 420 Pages
  • Global
From
Australia Pharmaceuticals Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028) - Product Thumbnail Image

Australia Pharmaceuticals Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

  • Report
  • April 2023
  • 90 Pages
  • Australia
From
Denmark Pharmaceutical Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028) - Product Thumbnail Image

Denmark Pharmaceutical Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

  • Report
  • April 2023
  • 80 Pages
  • Denmark
From
Fallopian Tube Cancer - Pipeline Review, H2 2020 - Product Thumbnail Image

Fallopian Tube Cancer - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 1722 Pages
  • Global
From
Bladder Cancer - Pipeline Review, H1 2020 - Product Thumbnail Image

Bladder Cancer - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 1855 Pages
  • Global
From
Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2020 - Product Thumbnail Image

Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 2815 Pages
  • Global
From
In Silico / Computer-Aided Drug Discovery Services Market: Focus on Large Molecules - Product Thumbnail Image

In Silico / Computer-Aided Drug Discovery Services Market: Focus on Large Molecules

  • Report
  • February 2020
  • 328 Pages
  • Global
From
Ovarian Cancer - Pipeline Review, H1 2020 - Product Thumbnail Image

Ovarian Cancer - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 3802 Pages
  • Global
From
Factor II (Prothrombin) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Factor II (Prothrombin) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Pancreatic Cancer - Pipeline Review, H2 2020 - Product Thumbnail Image

Pancreatic Cancer - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 4317 Pages
  • Global
From
Global Large Molecule Drug Substance CDMO Market Size, Share & Industry Trends Analysis Report By Application (Mammalian, Microbial and Others), By Service (Contract Manufacturing and Contract Development), By End-user, By Regional Outlook and Forecast, 2022 - 2028 - Product Thumbnail Image

Global Large Molecule Drug Substance CDMO Market Size, Share & Industry Trends Analysis Report By Application (Mammalian, Microbial and Others), By Service (Contract Manufacturing and Contract Development), By End-user, By Regional Outlook and Forecast, 2022 - 2028

  • Report
  • December 2022
  • 278 Pages
  • Global
From
The State of the Biopharmaceutical Industry 2024 Edition - Product Thumbnail Image

The State of the Biopharmaceutical Industry 2024 Edition

  • Report
  • December 2023
  • 110 Pages
  • Global
From
Computer-Aided Drug Discovery Services Market, 2018-2030 - Product Thumbnail Image

Computer-Aided Drug Discovery Services Market, 2018-2030

  • Report
  • June 2018
  • 315 Pages
  • Global
From
AL Amyloidosis - Market Insight, Epidemiology and Market Forecast - 2032 - Product Thumbnail Image

AL Amyloidosis - Market Insight, Epidemiology and Market Forecast - 2032

  • Report
  • March 2022
  • 166 Pages
  • Global
From
Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 99 Pages
  • Global
From
Graves' Ophthalmopathy - Pipeline Review, H1 2020 - Product Thumbnail Image

Graves' Ophthalmopathy - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 82 Pages
  • Global
From
Pharmaceutical Product & Preparations Manufacturing in Europe - Industry Market Research Report - Product Thumbnail Image

Pharmaceutical Product & Preparations Manufacturing in Europe - Industry Market Research Report

  • Report
  • November 2023
  • 16 Pages
  • Europe
From
Multiple Myeloma (Kahler Disease) Global Clinical Trials Review, H1, 2020 - Product Thumbnail Image

Multiple Myeloma (Kahler Disease) Global Clinical Trials Review, H1, 2020

  • Clinical Trials
  • February 2020
  • 2110 Pages
  • Global
From
Partnerships, Licensing, Investments, Mergers and Acquisitions Deals and Trends in Pharmaceuticals - June 2020 - Product Thumbnail Image

Partnerships, Licensing, Investments, Mergers and Acquisitions Deals and Trends in Pharmaceuticals - June 2020

  • Report
  • August 2020
  • 88 Pages
  • Global
From
Genmab A/S Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis - Product Thumbnail Image

Genmab A/S Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

  • Company Profile
  • June 2024
  • 50 Pages
From
Loading Indicator